Processing

(Image: Getty/wildpixel)

Delays at MSD’s CMO prompt Sinemet shortage

By Flora Southey

MSD has warned regulators to expect a shortage of its Parkinson’s medicine, Sinemet, due to production constraints at a contract manufacturer’s facility.